Janet Abrahm

Janet Abrahm

Auto-generated profile, based on publicly available information

Janet Abrahm

Dana-Farber Cancer Institute, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2008 in JAMA
Verified
Journal Article
Closed access
JAJanet L. Abrahm
Janet L. Abrahm
MBMichael B. Banffy
Michael B. Banffy
MHMitchel B. Harris
Mitchel B. Harris
As 1 of the 12,700 US cancer patients who, each year, develops metastatic spinal cord compression, Ms H wishes to walk and live her life. Sadly, this wish may be difficult to fulfill. Before diagnosis, 83% to 95% of patients experience back pain, which often is referred, obscuring the site(s) of the compression(s). Prediction of ambulation depends on a patient's ambulatory status before therapy and time between developing motor defects and starting therapy. Ambulatory patients with no visceral metastases and more than 15 days between developing motor symptoms and receiving therapy have the best rate of survival. To preserve ambulation and optimize survival, magnetic resonance imaging should be performed for cancer patients with new back pain despite normal neurological findings. At diagnosis, counseling, pain management, and corticosteroids are begun. Most patients are offered radiation therapy. Surgery followed by radiation is considered for selected patients with a single high-grade epidural lesion caused by a radioresistant tumor who also have an estimated survival of more than 3 months. Team discussions with the patient and support network help determine therapy options and include patient goals; assessment of risks, benefits, and burdens of each treatment; and discussion of the odds of preserving prognosis of ambulation and of the effect of therapy on the patient's overall prognosis. Rehabilitation improves impaired function and its associated depression. Clinicians can help patients cope with transitions in self-image, independence, family and community roles, and living arrangements and can help patients with limited prognoses identify their end-of-life goals and preferences about resuscitation and entering hospice.

1 August 2020 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
JTJane Delima Thomas
Jane Delima Thomas
RLRichard E. Leiter
Richard E. Leiter
JAJanet L. Abrahm
Janet L. Abrahm
JSJaclyn C. Shameklis
Jaclyn C. Shameklis
SKStephanie B. Kiser
Stephanie B. Kiser
ALAndrew J. Lawton
Andrew J. Lawton


8 November 2016 in JMIR Medical Informatics
Verified
Journal Article
Open access
DLDavid F Lobach
David F Lobach
EJEllis B Johns
Ellis B Johns
BHBarbara Halpenny
Barbara Halpenny
TSToni-Ann Saunders
Toni-Ann Saunders
JBJane Brzozowski
Jane Brzozowski
MCMary E Cooley
Mary E Cooley
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.

16 December 2021 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MCMary E. Cooley
Mary E. Cooley
EMEmanuele Mazzola
Emanuele Mazzola
NXNiya Xiong
Niya Xiong
FHFangxin Hong
Fangxin Hong
DLDavid F. Lobach
David F. Lobach
JAJanet L. Abrahm
Janet L. Abrahm

1 July 2014 in Practical Radiation Oncology
Verified
Journal Article
Open access
YTYolanda D Tseng
Yolanda D Tseng
MKMonica S. Krishnan
Monica S. Krishnan
JJJoshua A. Jones
Joshua A. Jones
ASAdam J. Sullivan
Adam J. Sullivan
DGDaniel Gorman
Daniel Gorman
TBTracy A. Balboni
Tracy A. Balboni
The American Society of Clinical Oncology has recommended tailoring palliative cancer care (PCC) to the distinct and complex needs of advanced cancer patients. The Supportive and Palliative Radiation Oncology (SPRO) service was initiated July 2011 to provide dedicated palliative radiation oncology (RO) care to cancer patients. We used care providers' ratings to assess SPRO's impact on the quality of PCC and compared perceptions of PCC delivery among physicians practicing with and without a dedicated palliative RO service. An online survey was sent to 117 RO care providers working at 4 Boston-area academic centers. Physicians and nurses at the SPRO-affiliated center rated the impact of the SPRO service on 8 PCC quality measures (7-point scale, "very unfavorably" to "very favorably"). Physicians at all sites rated their department's performance on 10 measures of PCC (7-point scale, "very poorly" to "very well"). Among 102 RO care providers who responded (response rate, 89% for physicians; 83% for nurses), large majorities believed that SPRO improved the following PCC quality measures: overall quality of care (physician/nurse, 98%/92%); communication with patients and families (95%/96%); staff experience (93%/84%); time spent on technical aspects of PCC (eg, reviewing imaging) (88%/56%); appropriateness of treatment recommendations (85%/84%); appropriateness of dose/fractionation (78%/60%); and patient follow-up (64%/68%). Compared with physicians practicing in departments without a dedicated palliative RO service, physicians at the SPRO-affiliated department rated the overall quality of their department's PCC more highly (P = .02). Clinicians indicated that SPRO improved the quality of PCC. Physicians practicing within this dedicated service rated their department's overall PCC quality higher than physicians practicing at academic centers without a dedicated service. These findings point to dedicated palliative RO services as a promising means of improving PCC quality.